NCT05189327RecruitingNot Applicable
Non-interventional Observational Prospective Longitudinal Study of the Incidence of Ulcerative Colitis and Crohn's Disease Among the Adult Population of the Republic of Kazakhstan
Kazakhstan Scientific Society for Study of intestine diseases1 site in 1 country2,000 target enrollmentStarted: December 10, 2021Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 2,000
- Locations
- 1
- Primary Endpoint
- To study the incidence of NUC and CD in the Republic of Kazakhstan
Study Overview
Brief Summary
The NUCaCD study aims to develop a reliable registry of patients suffering inflammatory bowel diseases in the Republic of Kazakhstan.
Detailed Description
The NUCaCD aims to study the prevalence of inflammatory bowel diseases in the Republic of Kazakhstan and create a reliable database, which will greatly facilitate future planning of the volume of health resources needed to address these diseases management and will help to optimize preventive measures and will support future research to better understand the etiology, new options treatment and factors affecting prognosis, relapses, development of complications and quality of life.
Study Design
- Study Type
- Observational
- Observational Model
- Other
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Availability of a signed informed consent form; or the presence of a disinterested witness if the patient is unable to examine and sign the consent form due to illiteracy or disability (for example, in the case of blindness);
- •The patient has a documented diagnosis of ulcerative colitis or Crohn's disease (endoscopy, histology, if indicated by radiation diagnostics);
- •Patients who have applied for treatment or are already taking treatment from a gastroenterologist / coloproctologist, including inpatients;
- •Citizenship of the Republic of Kazakhstan (or resides).
Exclusion Criteria
- •Patient takes part in an interventional clinical trial;
- •Patient is unable to follow the schedule of the visits;
- •Any condition that the PI believes would prevent a study participant from participating in the study.
Outcomes
Primary Outcomes
To study the incidence of NUC and CD in the Republic of Kazakhstan
Time Frame: 2 years
To study the incidence of NUC and CD in the Republic of Kazakhstan
Secondary Outcomes
- Conduct an analysis of the completeness of the diagnosis and compliance with the national guidelines for the diagnosis and treatment of ulcerative colitis and Crohn's disease(2 years)
- To study the patterns of the course of the disease and the treatment effect(2 years)
- Analysis of the relationship between management strategies and treatment outcomes(2 years)
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Enrolling By Invitation
Not Applicable
CorEvitas Inflammatory Bowel Disease (IBD) RegistryInflammatory Bowel DiseasesNCT03162549CorEvitas2,287
Completed
Not Applicable
Real World Data on Vedolizumab Concentration and Outcomes in Inflammatory Bowel Disease (IBD) Patients Switching From Intravenous (IV) to Subcutaneous (SC) Vedolizumab in University Hospital Center OsijekInflammatory Bowel DiseasesCrohn DiseaseColitis, UlcerativeNCT05504915Osijek University Hospital31
Recruiting
Not Applicable
Registry and Biorepository for IBD in Central TexasInflammatory Bowel DiseasesUlcerative ColitisCrohn DiseaseNCT04617184University of Texas at Austin1,000
Completed
Not Applicable
Volatile Organic Compounds (VOCs) in Active Inflammatory Bowel DiseaseIBDCrohn DiseaseUlcerative ColitisNCT04827368The Cleveland Clinic292
Recruiting
Not Applicable
A Study to Evaluate Biomarkers in Moderate to Severe Ulcerative Colitis (UC) Patients Treated With Different Targeted TherapiesInflammatory Bowel DiseasesUlcerative ColitisNCT05456893Central Hospital, Nancy, France95